Profen and Kefzol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Profen (ibuprofen) and Kefzol (cefazolin sodium). Common drug interactions include nausea among females and actinomycosis among males.
The phase IV clinical study analyzes what interactions people have when they take Profen and Kefzol. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Profen?
Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.
What is Kefzol?
Kefzol has active ingredients of cefazolin sodium. eHealthMe is studying from 628 Kefzol users. Check the latest studies of Kefzol.
35 people who take Profen and Kefzol together, and have interactions are studied.

What are the common drug interactions of Profen and Kefzol, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Oedema (fluid collection in tissue)
- Pulmonary embolism (blockage of the main artery of the lung)
- Agitation (state of anxiety or nervous excitement)
- Aphthous stomatitis (mouth ulcer)
- Arthralgia (joint pain)
- Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
- Asthenia (weakness)
- Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
- Cardiac disorder
male:
- Actinomycosis (infection that causes sores, or abscesses)
- Adjustment disorder
- Constipation
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Cough
- Deep vein thrombosis postoperative (blood clot in a major vein that usually develops in the legs and/or pelvis after operation)
- Deformity (disfigurement)
- Depression
- Diarrhoea
- Dry eye (lack of adequate tears)
What are the common drug interactions of Profen and Kefzol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Blood cholesterol increased
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholecystitis infective (infection of gallbladder capable to infect other organs)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Device failure
- Drug ineffective
- Gallbladder disorder
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
30-39:
- Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
- Cholecystitis chronic (long lasting infection of gallbladder)
- Gallbladder disorder
- Atrioventricular block complete (heart block complete)
- Cardiac failure
- Heart rate decreased
40-49:
- Pulmonary embolism (blockage of the main artery of the lung)
50-59:
- Nervousness
- Psychiatric symptom
- Renal impairment (severely reduced kidney function)
- Stress
- Anxiety
- Emotional distress
- Fear
- Injury
- Multi-organ failure (multisystem organ failure)
- Renal failure (kidney dysfunction)
60+:
- Nausea (feeling of having an urge to vomit)
- Oedema (fluid collection in tissue)
- Chest pain
- Constipation
- Contusion (a type of hematoma of tissue in which capillaries)
- Cyst (a closed sac)
- Decreased interest
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dehydration (dryness resulting from the removal of water)
- Depressed mood
What are the existing conditions these people have? *
- Birth Control: 6 people, 17.14%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.57%
- Premenstrual Syndrome: 3 people, 8.57%
- Traumatic Haemorrhage (a bleeding due to trauma): 2 people, 5.71%
- Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 5.71%
- Sedation: 2 people, 5.71%
- Inflammation: 2 people, 5.71%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.71%
- Fungal Infection: 2 people, 5.71%
- Bacterial Infection: 2 people, 5.71%
* Approximation only. Some reports may have incomplete information.
Do you take Profen and Kefzol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Profen and Kefzol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Profen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Kefzol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Profen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Kefzol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on ibuprofen and cefazolin sodium (the active ingredients of Profen and Kefzol, respectively), and Profen and Kefzol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Novothyrox and Agitation Aggravated for Women aged 40-49 - 5 seconds ago
- Could Vitamin E cause Vitreous Floaters? - 5 seconds ago
- Drug interactions of Xalatan and Benazepril Hydrochloride - 5 seconds ago
- Headache in Effexor, how severe and when it was recovered? - 10 seconds ago
- Ipratropium Bromide and Ards (Acute Respiratory Distress Syndrome) for Men aged 60+ - 10 seconds ago
- Ipratropium Bromide and Stiff Lung for Men aged 60+ - 11 seconds ago
- Ipratropium Bromide and Shock Lung for Men aged 60+ - 11 seconds ago
- Ipratropium Bromide and Non-Cardiogenic Pulmonary Edema for Men aged 60+ - 11 seconds ago
- Ipratropium Bromide and Increased-Permeability Pulmonary Edema for Men aged 60+ - 11 seconds ago
- Ipratropium Bromide and Acute Respiratory Distress Syndrome for Men aged 60+ - 12 seconds ago